These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22101134)

  • 1. LDV peptidomimetics equipped with biotinylated spacer-arms: synthesis and biological evaluation on CCRF-CEM cell line.
    Gérard E; Meulle A; Feron O; Marchand-Brynaert J
    Bioorg Med Chem Lett; 2012 Jan; 22(1):586-90. PubMed ID: 22101134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R₈ERY.
    Papst S; Noisier AF; Brimble MA; Yang Y; Krissansen GW
    Bioorg Med Chem; 2012 Sep; 20(17):5139-49. PubMed ID: 22877871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine-Aspartic Acid-Valine sequence as targeting ligand and drug carrier for doxorubicin delivery to melanoma cells: in vitro cellular uptake and cytotoxicity studies.
    Zhong S; Bhattacharya S; Chan W; Jasti B; Li X
    Pharm Res; 2009 Dec; 26(12):2578-87. PubMed ID: 19806436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.
    Peng L; Liu R; Marik J; Wang X; Takada Y; Lam KS
    Nat Chem Biol; 2006 Jul; 2(7):381-9. PubMed ID: 16767086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and assay of retro-α4β1 integrin-targeting motifs.
    Dattoli SD; De Marco R; Baiula M; Spampinato S; Greco A; Tolomelli A; Gentilucci L
    Eur J Med Chem; 2014 Feb; 73():225-32. PubMed ID: 24412498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of a series of peptidomimetic ligands for alpha(4) beta(1) integrin on Jurkat T-leukemia cells.
    Liu R; Peng L; Han H; Lam KS
    Biopolymers; 2006; 84(6):595-604. PubMed ID: 17041919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R₈ERY prepared via Click Chemistry: synthesis and biological evaluation.
    Papst S; Noisier A; Brimble MA; Yang Y; Krissansen GW
    Bioorg Med Chem; 2012 Apr; 20(8):2638-44. PubMed ID: 22421276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
    Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
    J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A graftable LDV peptidomimetic: design, synthesis and application to a blood filtration membrane.
    Momtaz M; Rerat V; Gharbi S; Gérard E; Pourcelle V; Marchand-Brynaert J
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1084-90. PubMed ID: 18155910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 4-Aminoproline-Based Small Molecule Cyclopeptidomimetics as Potential Modulators of α
    Sartori A; Bugatti K; Portioli E; Baiula M; Casamassima I; Bruno A; Bianchini F; Curti C; Zanardi F; Battistini L
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileukemic activity of aminoparthenolide analogs.
    Nasim S; Crooks PA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3870-3. PubMed ID: 18590961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S; Hartmann BL; Hattmannstorfer R; Löffler M; Ausserlechner MJ; Bernhard D; Sgonc R; Strasser-Wozak EM; Ebner M; Auer B; Kofler R
    Oncogene; 1997 Nov; 15(20):2429-37. PubMed ID: 9395239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
    Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of novel shikonin analogues.
    Wang W; Dai M; Zhu C; Zhang J; Lin L; Ding J; Duan W
    Bioorg Med Chem Lett; 2009 Feb; 19(3):735-7. PubMed ID: 19111464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors.
    Gomez C; Bai L; Zhang J; Nikolovska-Coleska Z; Chen J; Yi H; Wang S
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1733-6. PubMed ID: 19243938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 9-beta-d-arabinofuranosylguanine by combined use of two whole cell biocatalysts.
    Médici R; Iribarren AM; Lewkowicz ES
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4210-2. PubMed ID: 19523826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.